Valuation: DexCom, Inc.

Market Cap 2.76TCr 2.42TCr 2.25TCr 2.07TCr 3.89TCr 2,65800Cr 3.95TCr 27TCr 10TCr 1,30700Cr 10TCr 10TCr 4,51900Cr P/E 2026 *
29.1x
P/E 2027 * 24.3x
Enterprise Value 2.72TCr 2.39TCr 2.22TCr 2.04TCr 3.83TCr 2,61700Cr 3.89TCr 26TCr 10TCr 1,28700Cr 10TCr 9.98TCr 4,44900Cr EV / Sales 2026 *
5.2x
EV / Sales 2027 * 4.52x
Free-Float
93.35%
Yield 2026 *
-
Yield 2027 * -
1 day+1.50%
1 week-6.67%
Current month+6.22%
1 month+2.57%
3 months+16.19%
6 months-1.81%
Current year+7.79%
1 week 69.79
Extreme 69.79
77.08
1 month 67.3
Extreme 67.3
79.15
Current year 56.72
Extreme 56.72
79.15
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap.
20/07/26 Sell

Chairman

-26,756 0.0069%
15/07/26 Sell

General Counsel

-1,700 0.0004%
06/07/26 Sell

Chairman

-26,756 0.0069%
Change 5-day change 1-year change 3-year change Capi.($)
+1.50%-6.67%-17.52%-43.99% 2.76TCr
+2.29%+2.36%-17.97%-10.09% 18TCr
+1.46%+0.01%-9.87%-6.25% 11TCr
+1.58%+0.65%+6.69%+61.86% 6.03TCr
-1.13%-2.60%+26.37%+54.76% 5.02TCr
+2.22%-1.14%-14.85%-44.15% 4.31TCr
+2.98%-2.61% - - 3.28TCr
-7.67%-8.39%+17.59%-12.73% 2.31TCr
+1.63%-1.73%-5.80%-7.80% 2.09TCr
+0.30%-4.54%-16.61%-2.81% 1.95TCr
Average +0.52%-2.47%-3.55%-1.24% 5.63TCr
Weighted average by Cap. +1.25%-0.54%-7.00%+0.70%

Financials

2026 *2027 *
Net sales 522.4Cr 458.83Cr 426.7Cr 391.55Cr 735.7Cr 50TCr 747.04Cr 5.07TCr 1.98TCr 25TCr 1.96TCr 1.92TCr 86TCr 582.66Cr 511.75Cr 475.92Cr 436.72Cr 820.56Cr 56TCr 833.21Cr 5.65TCr 2.21TCr 28TCr 2.19TCr 2.14TCr 95TCr
Net income 96Cr 84Cr 78Cr 72Cr 135.12Cr 9.24TCr 137.2Cr 930.61Cr 363.58Cr 4.54TCr 360.18Cr 352.42Cr 16TCr 115.73Cr 101.65Cr 95Cr 87Cr 162.99Cr 11TCr 165.5Cr 1.12TCr 438.56Cr 5.48TCr 434.47Cr 425.1Cr 19TCr
Net Debt -43Cr -38Cr -35Cr -32Cr -60Cr -4.13TCr -61Cr -415.82Cr -162.46Cr -2.03TCr -160.94Cr -157.47Cr -7.02TCr -128.06Cr -112.48Cr -104.6Cr -96Cr -180.35Cr -12TCr -183.13Cr -1.24TCr -485.27Cr -6.06TCr -480.74Cr -470.38Cr -21TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
24/26/24 $71.54 +1.50% 28,44,471
23/26/23 $70.48 -1.33% 32,64,981
22/26/22 $71.43 -4.44% 38,70,980
21/26/21 $74.75 -1.24% 39,62,329
20/26/20 $75.69 -1.25% 31,88,475
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
71.54USD
Average target price
85.75USD
Spread / Average Target
+19.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock